IP Library Granted Patent US 9,932,591
Granted Patent B2
US 9,932,591 · App. 15/105,925 · Granted Apr 3, 2018

Reduction of lipase activity in product formulations

Inventors: Kelvin Lee (Newark, DE); Abraham Lenhoff (Newark, DE); Kristin Valente (Plymouth Meeting, PA); Nick Levy (Philadelphia, PA); Yatin Gokarn (San Diego, CA)
Assignee: University of Delaware
C12N15/1137A61K38/1709A61K38/1741A61K38/1761A61K38/1774A61K38/39A61K38/42A61K38/44A61K38/443A61K38/45A61K38/482A61K38/488A61K38/4813A61K38/52A61K47/26C07K16/00C12N9/20C12P21/005C12P21/02C12N2310/10C12N2310/14C12N2310/20C12Y104/03013C12Y111/01015C12Y205/01018C12Y207/04006C12Y207/11001C12Y301/01034C12Y304/16005C12Y304/21C12Y304/23005C12Y502/01008C12Y503/04001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,932,591
App. No.
15/105,925
Granted
Apr 3, 2018
Kind
B2
Abstract

The invention relates a method for producing a stable recombinant protein, comprising growing a non-naturally occurring host cell in a culture medium to produce a recombinant protein, and making a composition comprising the recombinant protein and a polysorbate. The production of endogenous lipoprotein lipase by the host cell is reduced. The endogenous lipoprotein lipase is present in the composition in a small amount, and is capable of degrading the polysorbate. The invention also relates to the relevant host cells and compositions, and preparation thereof.

Claims (4)

1. A non-naturally occurring host cell comprising a nucleic acid sequence encoding recombinant protein, wherein the host cell expresses the recombinant protein, wherein the host cell expresses an interfering RNA specific for an endogenous lipoprotein lipase, whereby the production of the endogenous lipoprotein lipase by the host cell is reduced.

2. The non-naturally occurring host cell of claim 1 , wherein the host cell is a mammalian cell selected from the group consisting of CHO, 3T3, BHK, HeLa, HepG2, and derivatives thereof.

3. The non-naturally occurring host cell of claim 1 , wherein the interfering RNA is selected from the group consisting of small interfering RNAs (siRNAs), short hairpin RNAs (shRNAs), and bifunctional RNAs.

4. The non-naturally occurring host cell of claim 1 , wherein the interfering RNA is encoded by the genome of the host cell.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jun 5, 2018
From: UNIVERSITY OF DELAWARE
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 046302/0794 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2017
From: LEE, KELVIN; LENHOFF, ABRAHAM; VALENTE, KRISTIN; LEVY, NICK
To: UNIVERSITY OF DELAWARE
Reel/Frame 044078/0647 →
CONFIRMATORY LICENSE Recorded Jul 12, 2017
From: UNIVERSITY OF DELAWARE
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 043170/0289 →
Continuity (2)
Provisional Application 61917555 · Dec 18, 2013
Related Publication 20160312226A1 · Oct 27, 2016